Tuesday, 7 April 2026
  
Login

Australia's most trusted
source of pharma news

Tuesday, 7 April 2026
Ascott 1
Ascott 1
Latest News
Four brands hit with price cuts

April has seen the first new brand competition for four PBS-listed drugs meaning they've been hit with a 25 per cent statutory reduction in price amounting to a total more than $30 million.

Event draws global thought leaders
Hundreds of prostate cancer experts from around the world descended on Melbourne to unpack advances in care
TODAY
After 1192 days, is funding in sight?
It's been over four years since the HTA process for this next-gen cancer treatment began but the wait may soon be over
TODAY
Most Popular
Who's on a major hiring spree?
This company has launched a massive recruitment drive, hunting for the best talent as it grows its business for the next chapter
2 April
Global pharma inks Arrotex deal
Strategic partnership will ensure continued access to the originator brand for Australian women with news a generic is also on the way
2 April
Seven novel drugs hit the PBS
Seven new treatments have been added to the PBS as of today, with a pharma pulling off two wins for separate cancer drugs
1 April
Aussie pharma exec wins CEO job
After decades working in pharma this familiar face has scored the top role at the Generic and Biosimilar Medicines Association
1 April
HPG
HPG
Latest Jobs
Pharma in Focus  Jobs

Marketing & Communications (2)

Sales & Customer Relations (14)

Clinical & Medical, R&D (6)

Regulatory, Pharmacovigilance & QA (4)

Executive Roles (2)

Other (7)

More News
And again... MA fills media role
Seasoned public affairs leader named as the industry body's new Senior Media Advisor, its sixth in as many years
TODAY
First oral SERD registered
Finally registered on the ARTG, marking the first oral SERD in Australia with the company actively seeking reimbursement
TODAY Approvals Action
Leaders ready to ignite debate
Organisers promise a sharper agenda and new practical workshops designed to equip pharma professions with instant skills
2 April
Sanofi applauds NIP law change
Expanding the scope of the National Immunisation Program to include non-vaccines, will allow for more uniform childhood protection
2 April
Novo's megastar notches a first
Provisional approval for Wegovy marks a significant milestone offering the first drug option available for this 'silent disease'
2 April
13 pharmas win April PBS listings
Companies win April PBS listings, with some even securing subsidy for more than one drug or for multiple indications
1 April New to the PBS
Another $20B spent on acquisitions
Two pharmas have ended the first quarter with announcements of major acquisitions, both expanding their reach into new markets
1 April
Company responds to sale rumours
Following swirling speculation that this company is being sold, a stock exchange announcement reveals there is, in fact, an offer
1 April
Aussie GM exits but where to next?
With two Country Leadership roles currently vacant, the quiet departure of this GM is raising questions about her next move
31 March
Pharma unveils a new name
By aligning under a single global brand, the company says it is better positioned to deliver a more consistent experience
31 March
Studying? Aussie uni smashing it
This University has risen two spots to be crowned #2 in the world for Pharmacy and Pharmacology, trailing only Harvard University
31 March
Will the stars align for biosims?
A collision of internal and external pressures on government could drive the bold policy change needed to boost biosim uptake
31 March
Companies on a buying blitz
Orphan drugs and novel treatments have caught the attention of big pharma, which has splashed $17.6 billion in the past week
31 March
Blockbuster scores triple PBS win
The most subsidised drug in Australia just got funded for even more indications, but is still aiming to avoid the long PBAC line
30 March
PiF Advertise
PiF Advertise
© 2003 - 2026 Lush Media | Privacy Statement | Subscribe to Pharma in Focus
home
Welcome to Pharma in Focus

Please log in to read.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.


Subscribe